Safety and efficacy of nicotinamide in the management of hyperphosphatemia in patients on hemodialysis

Hyperphosphatemia is an important modifiable risk factor for death and cardiovascular events in patients on hemodialysis (HD). As nicotinamide has been shown as an inhibitor of sodium–dependent phosphate co–transport in rat renal tubule and small intestine, we examined whether nicotinamide reduces h...

Full description

Saved in:
Bibliographic Details
Main Authors: Vasantha, J., Soundararajan, P., Vanitharani, N., Kannan, G., Thennarasu, P., Neenu, G., Reddy, C. Umamaheswara
Format: Artigo
Language:Inglês
Published: Medknow Publications 2011
Subjects:
Original Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3193667/
https://ncbi.nlm.nih.gov/pubmed/22022084
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0971-4065.83735
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items